Telecommunications & Broadcasting

SKSQUARE Reports Record-High 3Q Operating Profit of 7.9 Trillion Won... Half from INICS Corporation Equity Method Income

SK hynix Reports Strong Earnings, Reflecting Significant Equity Method Income Quarterly Operating Profit Exceeds 7 Trillion Won Over 60% of Ordinary Dividend Income and 100% of Special Dividends to Be Returned to Shareholders Rebalancing Accelerates with Sales of OneStore and Incross Co.,Ltd., Among Others

Yun Junghoon
2026-11-16 16:51:37
[Edaily Reporter Yun Junghoon ]SKSQUARE(402340)posted an operating profit of over 7 trillion won in the third quarter of this year, setting a new all-time high, driven by the strong earnings performance of SK hynix(000660).

SKSQUARE announced on the 16th that, based on consolidated financial statements, it recorded revenue of 304.8 billion won, operating profit of 7.9406 trillion won, and net income of 12.5344 trillion won in the third quarter of this year. Earnings surged significantly year-over-year, with equity method income alone totaling 7.9575 trillion won.

SKSQUARE (Photo: SKSQUARE)


Operating Profit Exceeds 7 Trillion Thanks to SK hynix… Record-Breaking Shareholder Returns

These strong results are directly attributable to the robust semiconductor performance of its subsidiary, SK hynix, and the resulting equity method income. SKSQUARE plans to significantly strengthen its shareholder return policy based on the secured funds.

SKSQUARE plans to return at least 4.3 trillion won to shareholders out of the more than 6.2 trillion won in dividend income generated from SK hynix’s cash dividends. Specifically, the company intends to return more than 60% of its ordinary dividend income by 2028 and allocate 100% of the special dividend income from SK hynix’s Kioxia investment to shareholder returns.

This represents an unprecedented level of shareholder returns, significantly exceeding the company’s previously announced policy (at least 30% of ordinary dividend income plus a portion of investment returns).

Accelerating
Portfolio Rebalancing… Evolving into an “AI-Native” Investment Firm

The investment portfolio is rapidly being restructured to focus on AI and semiconductors. In the first half of this year, SKSQUARE sold its app market subsidiary OneStore and digital advertising firm Incross Co.,Ltd., divesting non-core assets and accelerating its “selection and concentration” strategy.

The company plans to use the abundant cash reserves secured through dividend income and asset sales as capital for future investments in the AI and semiconductor sectors.

The company has also begun improving its internal operational infrastructure by integrating artificial intelligence (AI). Centered around the newly established “AI Innovation” division, it is driving a company-wide AX (AI Transformation) initiative.

The company has completed the development of “One Agent per Employee”—a tool that individual employees can use in their daily work—and has implemented it in operational settings. Additionally, it has built “Kiwi,” a data hub that automatically accumulates and manages internal data based on a Large Language Model (LLM) wiki, thereby maximizing organizational productivity.

Kim Jeong-kyu, President of SKSQUARE, stated, “We will continue to consistently return value to shareholders to enhance corporate value and carefully prepare for new investments.”

Economy

Corporation

IT·Science

Economy

LGELECTRONICS Increases R&D Investment by 27%… Capital Expenditures on HVAC Facilities Also Rise 2.7-Fold

LGELECTRONICS has invested approximately 3.6 trillion won in research and development (R&D) through the third quarter of this year. This represents an increase of more than 27% compared to the same pe…
2026-11-16 17:04:33

Corporation

'Balanced Growth in Fashion and Beauty' LF Reports 51.1 Billion Won in Q3 Operating Profit… Up 217%

LF achieved both revenue growth and improved profitability in the third quarter, driven by balanced growth across its in-house and imported fashion and beauty brands. LF(093050)According to the quarte…
2026-11-16 16:38:14

IT·Science

Boryung to Co-Market Celltrion Pharm Inc.’s Diabetes Drugs ‘Nesina’ and ‘Actos’… Secures 51.7 Billion Blockbuster Deal

Boryung(003850)and Celltrion Pharm Inc. will jointly market the “Nesina” and “Actos” product lines for the treatment of type 2 diabetes. The strategy is to expand their presence in the domestic diabet…
2026-11-16 16:58:03